Technologies for Diabetes Management 2017-2027: Forecasts, Players, Opportunities
LONDON, Aug. 14, 2017 /PRNewswire/ --
Glucose sensors, ketone sensors, insulin pens and pumps
Diabetes affects over 400 million people around the world. Advancements in sensing and communication technologies are enabling new devices to monitor glucose levels, deliver insulin and manage diabetes in ways that have never been possible before. This report covers the current and future technologies that will enable fully automated diabetes control and assist diabetic patients as part of a multi-billion dollar market.
Download the full report: https://www.reportbuyer.com/product/5059924/
This report from IDTechEx covers mature, growing and emerging fields in diabetes technology, researched through primary interviews with companies, physicians and diabetic individuals to establish how the technological roadmap for diabetes management will develop over the next decade.
Historically glucose levels have been monitored using disposable biosensors, whereby a drop of blood is placed on to a sensor and an associated reader provides the result. While the glucose test strip industry produces billions of single use sensors a year, cuts to medical budgets are driving profitability down. Current invasive methods of glucose monitoring result in low patient compliance, leading to poor glucose control and the associated long term health implications. These factors have led both start-ups and established players in the field to develop novel glucose sensing platforms based on alternative sampling sites and detection methods. Whilst many of these technologies will not be able to precisely replicate the accuracy of blood glucose measurements, some are making progress towards this goal and are achieving regulatory approval to commercialise products in to this emerging market.
Advancements in diabetes care are not limited to glucose monitoring, novel insulin delivery platforms provide another area of growth for the industry, with wearable insulin pumps now widely available. Such devices contain a range of sensors to that enable the safe and controlled delivery of insulin to a patient. Progression in both glucose monitoring and insulin delivery technologies are enabling the delivery of a previously conceptual artificial pancreas system, able to deliver controlled insulin doses, based on sensor outputs to optimise glucose levels. The market for these fully automated diabetes management systems is expected to reach $6.5 billion by 2027.
The report examines diabetes technologies across seven key areas:
Sensors for glucose monitoring - The established blood glucose market manufactures over 20 billion test strips annually, however, as is discussed here, several factors are restraining the profitability of the industry and driving technological changes.
Beyond blood glucose measurements - Glucose exists in biological fluids other than blood, continuous glucose monitors and wearable devices are gaining traction and seeing large uptake by consumers.
Sensors for Ketone monitoring - When blood glucose levels are too high, acidic ketone bodies, the by-product of improper metabolism build up in the blood stream, leading to potentially life threatening complications. The range of available biosensors to measure and quantify ketone levels are reviewed.
Smart insulin pens - Start-ups backed by large pharmaceutical companies are adding sensors and connectivity to insulin pens to unlock a range of analytical tools. Several leading start-ups an companies are profiled and their products discussed.
Insulin pumps: towards an artificial pancreas - Compared to insulin pens, insulin pumps offer a more controlled rate of hormone delivery. Discussed is the progress whereby combining pump technologies with continuous glucose monitoring platforms is leading to the development of an artificial pancreas device, offering real-time sensor automated insulin delivery in response to changing glucose levels.
Sensors for side effects - Covering the diverse utilisation of innovative sensor technologies across novel aspects diabetes care, including; sensors in wearable devices, the ability to monitor other end points such as diabetic neuropathy as well as assessing ulcer development in diabetic patients.
Sensors for early diagnosis - Discussing the use of emerging technologies to aid the early detection of diabetes, thereby preventing long hospital stays and other complications.
The report contains 10 year forecasts across all relevant market segments, detailing revenue predictions, and volumes across multiple sensing technologies.
IDTechEx has identified and profiled key players to build a comprehensive picture of the diabetes technology industry. Significant stakeholders have been identified and profiled through primary research and interviews to understand the technology roadmap of diabetes care and to give an insightful, contextual and timely analysis of the industry now and in the future, identifying factors crucial for the triumph of a company in this ever-growing field.
Download the full report: https://www.reportbuyer.com/product/5059924/
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com
SOURCE ReportBuyer
Share this article